Jiang, Libin https://orcid.org/0000-0003-2543-4721
Guo, Sitong
Li, Bin
Xiao, Su
Wang, Fei
Wei, Wenbin https://orcid.org/0000-0003-2386-0989
Article History
Received: 21 October 2024
Revised: 28 July 2025
Accepted: 26 August 2025
First Online: 30 September 2025
Competing interests
: Authors BL, SX are founders of Neurophth Biotechnology and author FW is an employee, of Neurophth Biotechnology, the sponsor of the investigational drug evaluated in this clinical trial. Neurophth holds intellectual property rights to the investigational product and may pursue its commercialisation based on trial outcomes. The authors declare no additional competing interests.